Biolytica raised €5.3M in a funding round in May 2023. The company is based in Zug, Switzerland. Investors in the round: Maximon Longevity Co-Investment Fund. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.